Management & Board
Our Board
Peptimmune is led by an experienced management team and board of directors with a track record of building successful commercial biotechnology companies.
Board
Thomas P. Mathers
President and Chief Executive Officer
Tom joined Peptimmune as president and CEO, and director in 2003. He has more than sixteen years of executive management, sales, and marketing experience in the life sciences and medical device industry. Mr. Mathers also serves on the Board of Directors for the Biotechnology…
M. James Barrett, PhD
General Partner, New Enterprise Associates
Jim Barrett earned a BS in Chemistry from Boston College, a PhD in Biochemistry from the University of Tennessee, and an MBA from the University of Santa Clara. He was employed until 1982 by the SmithKline and French Corporation (now GlaxoSmithKline), lastly as president of its…
Luke Evnin, PhD
General Partner, MPM Capital
Dr. Luke Evnin is a general partner at MPM Capital. Before joining MPM, Dr. Evnin was at Accel Partners for over seven years including four years as a general partner. He was involved in biopharmaceutical, pharmaceutical, medical device, and health-care service companies for…
Fredric D. Price
Executive Chairman
Fredric D. Price was elected executive chairman of the board of directors in August 2007. Mr. Price is also the chairman of the Board of Directors of Omrix Biopharmaceuticals (NASDAQ: OMRI), a member of the Board of Directors of Enobia Pharma, and a member of the Board of…
Management
Thomas P. Mathers
President and Chief Executive Officer
Tom joined Peptimmune as president and CEO, and director in 2003. He has more than sixteen years of executive management, sales, and marketing experience in the life sciences and medical device industry. Mr. Mathers also serves on the Board of Directors for the Biotechnology…
Eric H. Zanelli, PhD
Vice President, Research
Dr. Zanelli joined Peptimmune in 2003 as vice president of research and is a leading immunologist and HLA expert with experience in therapeutic development. Prior to Peptimmune, Dr. Zanelli was at Praecis Pharmaceuticals and Cardion AG, applying his expertise in autoimmune…
Carole Cassidy, MBA
Associate Director, Finance and Administration
Carole joined Peptimmune in 2005 and is responsible for all finance and administration. Prior to her role at Peptimmune, Carole worked in real estate development with Baren and Company. She earned her Bachelor's degree in Business Administration from the University of…
Uday Patel
Senior Director, Regulatory Affairs and Quality Assurance
Uday joined Peptimmune in 2004 as senior director of quality assurance and regulatory affairs and has more than fifteen years of experience in quality systems and regulatory affairs management of biotechnology and pharmaceutical product development. Prior to his role at…
Nicolas Mourier, PhD
Director, Product Development
Dr. Nicolas Mourier joined Peptimmune in 2008 as director of product development with more than fifteen years experience in pharmaceutical development. Prior to Peptimmune, Dr. Mourier was at Johnson Matthey and Wolfe Laboratories, where he held leadership positions in the…
